Michael Lane - Feb 13, 2025 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Signature
/s/ Lily J. Lu, Attorney-in-Fact for Michael Lane
Stock symbol
IDXX
Transactions as of
Feb 13, 2025
Transactions value $
-$120,912
Form type
4
Date filed
2/18/2025, 09:43 PM
Previous filing
Feb 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +160 +2.47% $0.00 6.65K Feb 14, 2025 Direct F1
transaction IDXX Common Stock Options Exercise $0 +204 +3.07% $0.00 6.85K Feb 14, 2025 Direct
transaction IDXX Common Stock Options Exercise $0 +220 +3.21% $0.00 7.07K Feb 14, 2025 Direct
transaction IDXX Common Stock Options Exercise $0 +301 +4.25% $0.00 7.38K Feb 14, 2025 Direct
transaction IDXX Common Stock Tax liability -$121K -272 -3.69% $444.53 7.1K Feb 14, 2025 Direct
holding IDXX Common Stock 592 Feb 13, 2025 by spouse F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award $0 +6.32K $0.00 6.32K Feb 13, 2025 Common Stock 6.32K $459.76 Direct F3
transaction IDXX Incentive Stock Option (right-to-buy) Award $0 +217 $0.00 217 Feb 13, 2025 Common Stock 217 $459.76 Direct F4
transaction IDXX Restricted Stock Unit Award $0 +1.47K $0.00 1.47K Feb 13, 2025 Common Stock 1.47K Direct F5
transaction IDXX Restricted Stock Unit Options Exercise $0 -160 -100% $0.00 0 Feb 14, 2025 Common Stock 160 Direct F6
transaction IDXX Restricted Stock Unit Options Exercise $0 -204 -50% $0.00 204 Feb 14, 2025 Common Stock 204 Direct F7
transaction IDXX Restricted Stock Unit Options Exercise $0 -220 -33.33% $0.00 440 Feb 14, 2025 Common Stock 220 Direct F8
transaction IDXX Restricted Stock Unit Options Exercise $0 -301 -25% $0.00 903 Feb 14, 2025 Common Stock 301 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes a total of 47 shares purchased under the Issuer Employee Stock Purchase Plan on March 29, 2024, June 28, 2024, September 30, 2024 and December 31, 2024.
F2 Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.
F3 Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2026.
F4 Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2029.
F5 Grant of restricted stock units ('RSU') that upon vesting, will be deferred and recorded in an account under the Issuer's Deferred Compensation Plan. This RSU grant vests in four annual installments, beginning February 14, 2026.
F6 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in four annual installments, beginning February 14, 2022.
F7 Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2023.
F8 Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024.
F9 Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025.